IDH Mutation
10 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Surgical Window of Opportunity Study of Orally Administered BAY 2402234 in Recurrent Glioma (NCT05061251) | University of Texas Southwestern Medical Center | 2021-12-01 |
| A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms (NCT04955938) | University of Chicago | 2021-10-29 |
| Metabolic Characterization of Space Occupying Lesions of the Brain (NCT04233788) | Insel Gruppe AG, University Hospital Bern | 2021-09-01 |
| Talazoparib - Carboplatin for Recurrent High-grade Glioma With DDRd (NCT04740190) | The University of Hong Kong | 2021-01-01 |
| Study of Olaparib and Durvalumab in IDH-Mutated Solid Tumors (NCT03991832) | University Health Network, Toronto | 2019-12-31 |
Track IDH Mutation automatically
Every clearance here is in the API, with alerts when new ones post.